Livero Inc. Fundamental Analysis (JPX: 9245.T)
Livero Inc. Fundamental Analysis (JPX: 9245.T)
Livero Inc. (JPX: 9245.T) shows strong financial fundamentals with a PE ratio of 12.59, profit margin of 17.06%, and ROE of 29.02%. The company generates $4.8B in annual revenue with strong year-over-year growth of 21.69%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 81.8/100 based on profitability, valuation, growth, and balance sheet metrics. The B+ grade reflects solid fundamentals with room for improvement in valuation or growth.
Fundamental Health Score
We analyze 9245.T's fundamental strength across five key dimensions:
Efficiency Score
Weak9245.T struggles to generate sufficient returns from assets.
Valuation Score
Excellent9245.T trades at attractive valuation levels.
Growth Score
Excellent9245.T delivers strong and consistent growth momentum.
Financial Health Score
Excellent9245.T maintains a strong and stable balance sheet.
Profitability Score
Moderate9245.T maintains healthy but balanced margins.
Key Financial Metrics
Is 9245.T Expensive or Cheap?
P/E Ratio
9245.T trades at 12.59 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 9245.T's PEG of 0.08 indicates potential undervaluation.
Price to Book
The market values Livero Inc. at 3.26 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 10.52 times EBITDA. This signals the market has high growth expectations.
How Well Does 9245.T Make Money?
Net Profit Margin
For every $100 in sales, Livero Inc. keeps $17.06 as profit after all expenses.
Operating Margin
Core operations generate 23.99 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $29.02 in profit for every $100 of shareholder equity.
ROA
Livero Inc. generates $9.14 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Livero Inc. generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Livero Inc. generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
9245.T converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
12.59
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.08
vs 25 benchmark
P/B Ratio
Price to book value ratio
3.26
vs 25 benchmark
P/S Ratio
Price to sales ratio
2.15
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.80
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.29
vs 25 benchmark
ROA
Return on assets percentage
0.09
vs 25 benchmark
ROCE
Return on capital employed
0.21
vs 25 benchmark
How 9245.T Stacks Against Its Sector Peers
| Metric | 9245.T Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 12.59 | 19.46 | Better (Cheaper) |
| ROE | 29.02% | 578.00% | Weak |
| Net Margin | 17.06% | 923.00% | Weak |
| Debt/Equity | 0.00 | -0.50 (disorted) | Distorted |
| Current Ratio | 1.80 | 1.91 | Neutral |
| ROA | 9.14% | 257.00% | Weak |
9245.T outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Livero Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
103.97%
Industry Style: Growth, Technology, Streaming
High GrowthEPS CAGR
135.67%
Industry Style: Growth, Technology, Streaming
High GrowthFCF CAGR
324.85%
Industry Style: Growth, Technology, Streaming
High Growth